Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager

All categories
Name
Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager
Accession Number
DBCAT005778
Description

Not Available

Drugs
DrugDrug Description
TeclistamabA bispecific B-cell maturation antigen (BCMA)-directed CD3 T cell engager used to treat relapsed and refractory multiple myeloma in adults as monotherapy.
ElranatamabA bispecific antibody used to treat adults with relapsed or refractory multiple myeloma.
Drugs & Drug Targets
DrugTargetType
TeclistamabT-cell surface glycoprotein CD3target
TeclistamabTumor necrosis factor receptor superfamily member 17target
ElranatamabTumor necrosis factor receptor superfamily member 17target
ElranatamabT-cell surface glycoprotein CD3target